Selling powdered milk might not sound like an exciting business, but don't say that around executives at Mead Johnson (NYSE:MJN) and Abbott Labs (NYSE:ABT). Both companies sport sizable consumer nutrition businesses, and some recent regulation changes in Hong Kong made headlines given their potential impact on powdered milk (e.g., infant formula) sales in the region. Follow along in the video below as Brenton Flynn and Max Macaluso discuss whether this is news that long-term investors should be concerned about, or noise they can ignore.

Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.